Macrophage checkpoint blockade: results from initial clinical trials, binding analyses, and CD47-SIRPα structure–function is a research paper published in Antibody Therapeutics (2020). On theSindex it has a DataRank of 0. It has been cited 115 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Science Foundation Graduate Research Fellowship Program
Grant: DGE-1845298
National Institutes of Health
Grant: DMR-1120901
National Institutes of Health
Grant: U54-CA193417-05
National Institutes of Health
Grant: R01-HL124106-06
NCI NIH HHS
Grant: U54 CA193417
NHLBI NIH HHS
Grant: R01 HL124106
National Institutes of Health
Grant: 2R01HL124106-05A1
Nanoscience of Self 2.0: blocking CD47 recognition by phagocytes in blood & solid tumor clearance
National Institutes of Health
Grant: 1U54CA193417-01
Core 2: Theory Core - Multiscale models for mechano-chemical phenomena
National Science Foundation
Grant: 1120901
Center of Excellence for Materials Research and Innovation
National Science Foundation
Grant: 1845298
Graduate Research Fellowship Program(GRFP)
National Science Foundation
FWCI
6.16
Citation Percentile
1.0%
Influential Citations
1
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals
Additional file 1 of CD47xCD19 bispecific antibody triggers recruitment and activation of innate immune effector cells in a B-cell lymphoma xenograft model
Additional file 1 of CD47xCD19 bispecific antibody triggers recruitment and activation of innate immune effector cells in a B-cell lymphoma xenograft model
Additional file 2 of CD47xCD19 bispecific antibody triggers recruitment and activation of innate immune effector cells in a B-cell lymphoma xenograft model
Additional file 2 of CD47xCD19 bispecific antibody triggers recruitment and activation of innate immune effector cells in a B-cell lymphoma xenograft model